Status:
COMPLETED
Smart Watch iECG for the Detection of Cardiac Arrhythmias
Lead Sponsor:
Helios Health Institute GmbH
Collaborating Sponsors:
Heart Center Leipzig - University Hospital
Conditions:
Arrhythmias, Cardiac
Atrial Fibrillation
Eligibility:
All Genders
22+ years
Brief Summary
This study aims to assess the feasibility and reliability of smart watch iECG provided by the Apple Watch/Apple iPhone for the detection of different cardiac arrhythmias. In this study, results from a...
Detailed Description
This diagnostic accuracy study is an investigator-initiated trial to evaluate the value of a smart watch-based iECG for detection of cardiac arrhythmias. iECG tracings will be recorded simultaneously...
Eligibility Criteria
Inclusion
- Patients aged≥22 years at the time of eligibility screening will be included.
- Patients with known cardiac arrhythmias; i.e. AF before and after cardioversion, hemodynamically stable Bradycardias, SVT and VT during EP procedures and implants can also be included
Exclusion
- \- Pregnancy
Key Trial Info
Start Date :
September 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04092985
Start Date
September 30 2019
End Date
July 30 2021
Last Update
October 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andreas Bollmann
Leipzig, Germany, 04289